Estimates of economies of scale and weak cost complementarities (WCC)
| Service-specific economies of scale | |
| Y1 (FP) | 0.005 |
| Y2 (PNC) | 0.001 |
| Y3 (Ca Cx screening) | 0.002 |
| Y4 (HCT) | 1.002 |
| Y5 (STI treatment) | 0.039 |
| Y6 (HIV care) | 0.158 |
| Ray economies of scale | −0.001 |
| WCC | |
| Y1 (FP)×Y4 (HCT) | 0.03 |
| Y2 (PNC)×Y4 (HCT) | 0.03** |
| Y3 (Ca Cx screening)×Y4 (HCT) | 0.02 |
| Y1 (FP)×Y5 (STI treatment) | −0.10*** |
| Y2 (PNC)×Y5 (STI treatment) | −0.06* |
| Y3 (Ca Cx screening)×Y5 (STI treatment) | −0.57*** |
| Y1 (FP)×Y6 (HIV care) | −0.00 |
| Y2 (PNC)×Y6 (HIV care) | −0.03** |
| Y3 (Ca Cx screening)×Y6 (HIV care) | −0.13*** |
***, ** and * denote significance at the 1%, 5% and 10% levels, respectively.
FP, family planning; PNC, post-natal care; STI, sexually transmitted infections.